Earlier we have reported on the expression of TGF-β1, plasminogen activator inhibitor (PAI)-1 and fibronectin (both target gene products of TGF-β1) and αvβ6 (activator of TGF-β1) in cervical carcinoma (Hazelbag et al, 2002, 2004, 2007). Here, TGFB1 is linked to cervical carcinoma.